MedTrace Logo

Pilot Study on Follow-Up of (Acutely) Suicidal Individuals From the Flemish Suicide Helpline

NCT07343258 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2026-02-19

No results posted yet for this study

Summary

This pilot study aims to assess the acceptance, feasibility, and added value of follow-up calls at the suicide helpline, Zelfmoordlijn 1813, in Flanders (Belgium). It serves as a crucial preparatory step in the development and implementation process of the callback methodology at Zelfmoordlijn 1813.

Conditions

  • Suicide
  • Suicidal Ideation and Behavior
  • Crisis Intervention

Interventions

OTHER

Callbacks from the Zelfmoordlijn 1813

Callers of Zelfmoordlijn 1813 are called back after their initial conversation, in which they themselves contacted the Zelfmoordlijn 1813. The callbacks focus on crisis management at the Zelfmoordlijn 1813 and are not intended as a form of formal support. During the callback calls, the specific needs of the caller are addressed, tailored to the callback profile assigned by a call responder based on the initial call. There are three different callback profiles for callers: (1) those for whom the crisis call immediately focuses on creating safety, with the callback calls further reinforcing this safety, (2) those for whom the focus is on crisis management, with follow-up aimed at developing and implementing a Safety Plan, and (3) those who experience barriers to discussing their suicidal thoughts, with the callback conversations being used to facilitate the step towards professional help or to make suicide discussable within their own network or existing support services.

Sponsors & Collaborators

  • University Ghent

    lead OTHER

Principal Investigators

  • Gwendolyn Portzky, PhD · University Ghent

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-05
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07343258 on ClinicalTrials.gov